血液前白蛋白/纤维蛋白原比值对胶质瘤患者的预后价值
研究探讨术前白蛋白、纤维蛋白原、前白蛋白、白蛋白/纤维蛋白原比值及前白蛋白/纤维蛋白原比值(PFR)对胶质瘤患者预后的预测价值。结果显示PFR(HR 2.827,95%CI 1.353-6.122,P=0.006)是唯一独立预后因素,含PFR的列线图c-index为0.719,高于不含PFR的0.699。
要点
- 术前PFR是胶质瘤患者的独立预后因素(HR 2.827,95%CI 1.353-6.122,P=0.006)。
- 含PFR的预测列线图c-index为0.719,高于不含PFR的0.699。
- 循环术前PFR可能是胶质瘤潜在的阴性独立预后生物标志物。
核心结论
- 术前循环PFR可能是胶质瘤患者潜在的阴性独立预后生物标志物。
研究设计与样本
- 研究采用X-tile软件确定各参数的截断值,使用Kaplan-Meier生存分析及基于Cox比例风险回归模型的单因素和多因素分析,并采用Harrell一致性指数评估预后准确性。
主要发现
- PFR(HR 2.827,95%CI 1.353-6.122,P=0.006)是胶质瘤患者唯一的独立预后因素,同时临床病理分级和年龄也是独立预后因素。
- 含PFR的预测列线图c-index为0.719,高于不含PFR的0.699。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Hematologic biomarkers that reflect host nutritional and inflammation status have been identified to be independent prognostic factors in various malignancies. The aim of the present study was to determine the predictive value of preoperative albumin, fibrinogen, prealbumin, albumin/fibrinogen ratio, and prealbumin/fibrinogen ratio (PFR) for the prognosis of patients with glioma. METHODS: X-tile software was used to identify cutoff values of these parameters. Kaplan-Meier survival analysis and univariate and multivariate analyses based on a Cox proportional hazards regression model were used to determine whether these markers were associated with the prognosis of patients with glioma. In addition, the Harrell concordance index with variables was used to evaluate the prognostic accuracy. RESULTS: The results indicated that PFR (hazard ratio, 2.827; 95% confidence interval, 1.353-6.122; P = 0.006) is the only independent prognostic factor in patients of glioma along with clinicopathologic grade and age. c-index of predicted nomogram including PFR (0.719) for patients with glioma was higher than that without PFR (0.699). CONCLUSIONS: Our findings show that circulating preoperative PFR might be a potential negative independent prognostic biomarker for individuals with glioma.
引用
- Hou S, Jin C, Yang M, et al. Prognostic Value of Hematologic Prealbumin/Fibrinogen Ratio in Patients with Glioma. World Neurosurg. 2022. PMID: 35051638. doi:10.1016/j.wneu.2022.01.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。